The frequency of IDH1 mutation in lower-grade glioma, however, was conspicuously high (77%) in TCGA_PanCancer, with cholangiocarcinoma and acute myeloid leukemia much lower at 14% and <10%, respectively (Figure 2A). This evidence concerns the gene IDH1 and cholangiocarcinoma.